In the transition from fetal to neonatal life, the kidneys undergo delicate and intricate changes in functionality as they assume the primary responsibility for keeping the blood clean and chemically balanced. Understanding these complex physiological changes is critical, as stressors before, during, and after delivery put newborns at risk of kidney injury and maladaptation. The… Read More
Next time you hop in a Lyft, you can know it was (hopefully) cleaned with methods developed in Memphis. The rideshare company worked with the University of Tennessee Health Science Center (UTHSC) and P&G Professional to develop a clean ride guide. The recommended vehicle cleaning process was developed specifically for rideshare vehicles. October 13:WMC Action… Read More
A third clinical trial that focused on COVID-19 was put on hold. Eli Lilly announced they stopped their study due to safety reasons. Dr. Scott Strome, a research doctor, believed people shouldn’t be concerned about this because it shows companies care about the process. “In an ideal world with drug development it would be great… Read More
The Hamilton Eye Institute at The University of Tennessee Health Science Center, improving vision and empowering lives, is pleased to welcome Claire L. Kiernan, MD as a staff member. Dr. Kiernan joins the practice following her Glaucoma fellowship at Tufts Medical Center where she practiced with the New England Eye Center, Ophthalmic Consultants of Boston… Read More
UTHSC Hamilton Eye Institute at The University of Tennessee Health Science Center dedicated to improving vision and empowering lives, welcomes Joshua R. Ford, MD as a staff member.
Memphis Medical News: Wei Li, PhD, professor in the Department of Pharmaceutical Sciences in the University of Tennessee Health Science Center’s College of Pharmacy, has been appointed a UTHSC Distinguished Professor. The title is reserved for those who have contributed in a superlative way to UTHSC and brought distinction and respect to the university.
The University of Tennessee Health Science Center and Regional One Health have announced they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19.
In March 2020, a deliberate misinformation campaign spread fear among the American public by propagating the false story that a nationwide quarantine to contain the coronavirus pandemic was imminent.
